Page 48 - Read Online
P. 48

Page 4 of 4                Orsucci et al. Neuroimmunol Neuroinflammation 2018;5:6  I  http://dx.doi.org/10.20517/2347-8659.2017.66


                                                   [6]
               fetal PCA and ischemic stroke is debated , fetal PCA may have some hemodynamic impact (e.g. faster
                                                                    [7]
               perfusion transit times ipsilateral to fetal origin of the PCA) , and a detrimental interaction of the two
               factors (hemodynamics and coagulation) cannot be ruled out.
               In conclusion, hematologists, geneticists and neurologists should be aware of this condition, which in most
               cases may easily be detectable on routine assays, and hypodysfibrinogenemia should be included among the
                                [8]
               monogenic diseases  associated with ischemic stroke in younger adults.

               DECLARATIONS
               Authors’ contributions
               Prepared the manuscript: Orsucci D
               Revised the manuscript: Mazzoni M
               Clinically studied the patient: Salvetti S, Vista M
               Performed the hematological examinations: Margelli M
               Performed the angiographic studies: Puglioli M


               Financial support and sponsorship
               None.


               Conflicts of interest
               There are no conflicts of interest.


               Patient consent
               The manuscript does not contain patient identifiable data.


               Ethics approval
               Not applicable.

               Copyright
               © The Author(s) 2018.

               REFERENCES
               1.   Mielke CH Jr, Kaneshiro MM, Maher IA, Weiner JM, Rapaport SI. The standardized normal Ivy bleeding time and its prolongation by
                   aspirin. Blood 1969;34:204-15.
               2.   Asselta R, Duga S, Tenchini ML. The molecular basis of quantitative fibrinogen disorders. J Thromb Haemost 2006;4:2115-29.
               3.   Lounes KC, Soria C, Mirshahi SS, Desvignes P, Mirshahi M, Bertrand O, Bonnet P, Koopman J, Soria J. Fibrinogen Alès: a homozygous
                   case of dysfibrinogenemia (gamma-Asp(330)-->Val) characterized by a defective fibrin polymerization site “a”. Blood 2000;96:3473-9.
               4.   Jood K, Danielson J, Ladenvall C, Blomstrand C, Jern C. Fibrinogen gene variation and ischemic stroke. J Thromb Haemost 2008;6:897-
                   904.
               5.   Neerman-Arbez M, Germanos-Haddad M, Tzanidakis K, Vu D, Deutsch S, David A, Morris MA, de Moerloose P. Expression and analysis
                   of a split premature termination codon in FGG responsible for congenital afibrinogenemia: escape from RNA surveillance mechanisms in
                   transfected cells. Blood 2004;104:3618-23.
               6.   Arjal RK, Zhu T, Zhou Y. The study of fetal-type posterior cerebral circulation on multislice CT angiography and its influence on cerebral
                   ischemic strokes. Clin Imaging 2014;38:221-5.
               7.   Wentland AL, Rowley HA, Vigen KK, Field AS. Fetal origin of the posterior cerebral artery produces left-right asymmetry on perfusion
                   imaging. AJNR Am J Neuroradiol 2010;31:448-53.
               8.   Mancuso M, Orsucci D, Ienco EC, Brondi M, Simoncini C, Chiti A, Montano V, Terni E, Giannini N, Siciliano G, Bonuccelli U. Common
                   genetic conditions of ischemic stroke to keep in mind. Curr Mol Med 2014;14:979-84.
   43   44   45   46   47   48   49   50   51   52   53